China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)

Overview

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., a prominent entity in the pharmaceutical industry, delves into the research, development, production, and distribution of an extensive range of pharmaceutical products. Founded in 1999 and originally known as Sanjiu Pharmaceutical Co., Ltd., it was rebranded in February 2010 to its current designation. Headquartered in Shenzhen, within the People's Republic of China, the company has fortified its presence both domestically and on the international stage. Beyond its comprehensive pharmaceutical products, it extends its capabilities to offering related health services, demonstrating a holistic approach to healthcare and well-being.

Products and Services

China Resources Sanjiu Medical & Pharmaceutical has fostered a robust portfolio that spans across various domains, including Over The Counter (OTC) products, prescription medicines, traditional Chinese medicine, along with innovative medical treatments in key health areas. Below is a detailed glance at their offerings:

• OTC Products: This category encompasses medicines for common health issues such as colds, skin ailments, gastrointestinal problems, coughs, orthopedic conditions, and pediatric concerns. These accessible healthcare solutions cater to everyday needs without the requisite of a prescription.
• Prescription Drug Products: Focused on addressing more specific and severe health conditions, the prescription medications cover traditional Chinese medicine approaches and modern treatments for tumors, cardiovascular and cerebrovascular diseases, ailments of the digestive system, orthopedics, and pediatric healthcare. These are designed to cater to the nuanced healthcare needs of individuals.
• Chinese Medicine Injections: A niche yet integral part of their offerings, these injections incorporate the philosophies of traditional Chinese medicine, aiming to offer therapeutic benefits through intravenous or other injectable means. It highlights the company's dedication to blending traditional practices with modern healthcare systems.
• Formula Granules: This innovative approach to traditional Chinese medicine involves providing herbal medicines in granulated form, facilitating easy consumption and assimilation. These granules are especially tailored for various conditions, adhering to the principles of traditional treatments while embracing modern convenience and precision.
• Anti-Infective Drugs: Targeting infections through a comprehensive range of antibiotics and antiviral medications, this segment is pivotal in combating infectious diseases. The dedication to developing advanced anti-infective solutions underscores the company's commitment to addressing emerging global health challenges.